Potential Risks of Cancer, Flu, MS Drugs to be Probed

by Rajshri on  February 18, 2010 at 7:45 PM Drug News   - G J E 4
 Potential Risks of Cancer, Flu, MS Drugs to be Probed
The Food and Drug Administration is to probe the potential risks of cancer, flu and multiple sclerosis drugs manufactured by Roche Holding AG, Novartis AG and other companies.

The move follows reports of hearing loss related to Novartis cancer drug Gleevec, hypothermia with Roche's flu drug Tamiflu and pericarditis with Biogen Idec and Elan Corp's multiple sclerosis drug Tysabri. The probes are being initiated mon issues with drugs reported between April 2009 and September 2009.

However the FDA cautioned that "Being on the list does not mean that FDA has identified a causal relationship between the drug and the listed risk."
The other drugs being probed include rheumatoid arthritis drugs known as tumor necrosis factor (TNF blockers), which have been linked to a neurological disorder called demyelinating neuropathy.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like